Implementing continuous process and real time release as a supplemental application change of an approved manufacturing product (a Case Study)

Size: px
Start display at page:

Download "Implementing continuous process and real time release as a supplemental application change of an approved manufacturing product (a Case Study)"

Transcription

1 Implementing continuous process and real time release as a supplemental application change of an approved manufacturing product (a Case Study) Eric Sanchez, MS Global Technical Services, Director Solids Platform Janssen Ortho, LLC

2 Presentation content The business case for continuous process and real time release Strategic approach for the process transformation Creating a multifunctional team and project management Continuous Process and PAT Development strategy Partnership with academia Project progress status Process development PAT development Line integration and qualification

3 Why pursuing continuous process transformation? It makes sense from many important aspects of a pharmaceutical production! A continuous process greatly improve material handling and is an enabler for JIT and demand pull Move to Area Move to Area FIFO Weight / Dispense Kanban Move to Area Weight / Dispense Delumping/ Milling Blending Multiple Areas and Handoffs FIFO Move to Area One Room, No Handoffs Move to Area Move to Area FIFO Packaging Kanban Tablet Coating Tablet Compression

4 Continuous Process and Real Time Release Business Case A quantum leap in process knowledge Quality and Savings Source Batch process Continuous Testing In-process tests & release tests with a cycle time of +30 days On line, at line tests: Cycle time of 5 days Smaller Footprint 7 rooms, 6 discrete pieces of equipment, 80% cost reduction 2 room, 1 equipment train 60% cost reduction Waste 3% 1% 66% yield improvement Capital Investment (for same capacity) $24 MM (est.) $12.4 MM 50% cost reduction

5 Continuous process Business Case- Reliability of Supply Source Current Future Mfg cycle time (dispensing thru coating) 13 days/1000 kg 1.1 days/1000 kg > 90% reduction Release 30+ days 5 days >80% reduction Flexibility of Supply Batch size changes require exp and validation batches No scale up/down Quality control Process Knowledge and controls Ca 10 out of 265,000 tablets measured/examined (for a 600 mg batch) Limited based on unit operation and in process control (IPC s) On/at line measurement measures CU directly, assay continuously! Full controls integration with PAT capability provides process information real time with capabilities of advanced process control More informtion than ever

6 Development strategy Industry / Academia / Government collaboration

7 Development strategy Use of ERC resources Raw material characterization Equipment characterization PAT interface development Continuous process DOE Continuous process samples for in vitro dissolution study Spectroscopic methods evaluation and selection NIR calibration method development for blend and tablets Development of dynamic blend sensing requirements and PAT interface development

8 Full application of Quality by Design Principles Risk Assessment DOE proposal Model base control DOE analysis

9 Quality by Design Considerations: Raw Materials Raw materials properties Raw material physical characteristics Materials flow, compressibility, material shear and electrical properties evaluation Safety aspects of materials handling (explosion mitigation)

10 Quality by Design considerations: Feeding Feeding system Feeding systems optional design aspects selection for each raw materials (feeders screw design (size or type), use of screen at outlet spout)

11 Quality by Design Considarations: Feeding Feeding system Feeding adequacy assessment Feeders re-fill strategy Allowable perturbation levels (minor and major components) Effect of material transfer on feeding consistency and materials mass balance Feeders variation filterability (Blender-Feeder relationship)

12 Quality by Design considerations: Blending Blending system Blend system adequacy Selection of Optional blender blade design and configuration Residence time distribution studies Blend transfer and evaluation of blend (IP test and sensing) Blend parametric DoE aspects in design space study e.g, Throughput, Blender RPM

13 Quality by Design Considerations: Compression Tablet compression process Compression control considerations Effect on compression properties with composition variation (compressibility modeling) Residence time distribution studies Design space aspects of compression (e.g. Throughput = compression speed, composition variation, feed frame RPM, compression force and tablet properties)

14 Quality by Design Considerations: Compression Tablet compression IPC Compression IPC considerations IPC design = physical properties, NIR models (Calibration and ID) NIR Model development aspects Demonstrated Intended use: Real time measurement (effect of time and environment on either model predictions = method ruggedness) Final concentration and content uniformity for acceptance (e.g. Demonstrated adequacy of Calibration model precision, intermediate precision, accuracy, statistical similarity and method concordance with HPLC methodology) Final product identity for acceptance (e.g. Foreign material identification, raw material (active and excipients) concentration out of limits)

15 Quality by Design Considerations: Compression Tablet transfer and film coating considerations Tablet relaxation dynamics considerations Time to coat vs Time to expand Design aspects of tablet transfer coordination and integration of tablet transfer elements to allow tablet acceptance/rejection safeguards and relaxation dynamics requirements Film coating process DoE aspects (weight gain, process thermodynamic balance, tablets appearance as a response) Overall DoE considerations (effect on dissolution at variable tablet properties)

16 Quality by Design Considerations: Compression Parametric controls CPP definition, DoE based PAR and Equipment Variation Range definitions Feeders = Scada system controls limits based on DoE and Feeders characterization study results CPP = Rate of Feeding, re-fill levels, screw speed, Blender = DoE blending study, blender speed (RPM) Tablet press = Throughput speed, feed frame speed, compression force, fill depth, in process physical properties (Multivariable control scheme) Coating = Process thermodynamic balance

17 Quality by Design Considerations: Compression Model Based controls (future goal) Use predictive models for control assessment and actions real time Feeders = Fourier transformed on feeders rate variation Blender = Taylor dispersion model, mean center variance on residence time distribution Tablet press = multivariable models, density base models Coating = Process thermodynamic models

18 Process and PAT development status Development milestones achieved Raw material characterization Automated dispensing (feeders) characterization Continuous blending design and characterization NIR PCA identity model and PLS Calibration model for API (blend and tablets) Use of Rutgers pilot line for the selected product Continuous Process Development DOE (Throughput, Blender Speed and configuration, Compression force) In vitro comparability completed, F1 and F2 comparability requirements pass DOE analysis completed 18

19 % LC % LC % LC % LC In vitro comparability results Regulatory Method N HCL f2 75 f f2 99 f Lot: Current 12MG0048 process Lot Run: 0-B Lot. Current 12MG0048 process Lot Run: 0-B M Phophate Buffer ph M Phophate Buffer ph 4.5, 6.5, 6.8 and 7.5 Max F1 = 13 Min F2 = f2 69 f Lot: Current 12MG0048 process Lot Run: 0-B Reference: Phosphate buffer ph 4.5 New Process: Phosphate buffer ph 4.5 Reference: Phosphate Buffer ph 6.5 Reference: Phosphate Buffer ph 6.8 Reference - Phosphate Buffer ph 7.5 New Process - Phosphate Buffer ph 6.5 New Process - Phosphate buffer ph

20 Dissolution Prediction and Controls = Surrogated Dissolution Proposal Dissolution predictive elements Dissolution Control Elements Multivariable thermodynamic control, empirical DS control API API Particle Size (COA) and Concentration control Film coating factors PAT? Disintegrant efficiency Disintegrant moisture and concentration control Multivariate (tablet IP, CPP, IPP) control Compression factors Blend lubrication Blender and feed frame shear control

21 Thanks to the teams!

22 Project status Project milestones achieved (JSC Gurabo facility) Facility construction completed Equipment installation completed Equipment qualification completed Controls design completed Controls testing (SAT on going) DoE design space confirmation on going Next steps Line integration, and PQ Registration lost manufacturing FDA s pre-operational meeting snda submission 22

23 The line at a glance (pre equipment installation)

24 The line at a glance (during equipment installation) Third Level First Level Panoramic View First Level Second Level First Level

Workshop B Control Strategy

Workshop B Control Strategy ICH-GCG ASEAN Workshop B Control Strategy Jean-Louis ROBERT, Ph.D. National Health Laboratory, Luxembourg Chair-person ICH IWG Q8, Q9, Q10 Kuala Lumpur, 26-28 July 2010 International Conference on Harmonisation

More information

QbD in der Praxis systematisches Vorgehen bei der Entwicklung pharmazeutischer Herstellprozesse. Adrian Funke

QbD in der Praxis systematisches Vorgehen bei der Entwicklung pharmazeutischer Herstellprozesse. Adrian Funke QbD in der Praxis systematisches Vorgehen bei der Entwicklung pharmazeutischer Herstellprozesse Adrian Funke Symposium der Fachgruppe Arzneimittelkontrolle / Pharmazeutische Analytik der DPhG Freiburg

More information

Multivariate Chemometric and Statistic Software Role in Process Analytical Technology

Multivariate Chemometric and Statistic Software Role in Process Analytical Technology Multivariate Chemometric and Statistic Software Role in Process Analytical Technology Camo Software Inc For IFPAC 2007 By Dongsheng Bu and Andrew Chu PAT Definition A system Understand the Process Design

More information

Process Validation Protocol (Reference: SOP )

Process Validation Protocol (Reference: SOP ) Project Name Equipment Manufacturer Process Line/Location Project Number Serial Number Model Number Protocol number [Enter Product Title, Number & Strength] MULTI VITAMIN TABLETS PRODUCT CODE: Name: Position:

More information

TABLET REFORMULATION CASE STUDY. Executive Summary

TABLET REFORMULATION CASE STUDY. Executive Summary TABLET REFORMULATION Executive Summary A large European pharmaceutical company contracted Aptuit to reformulate a tablet with existing dosage strengths of 25 mg and 50 mg. The client required smaller strengths

More information

IN VITRO BINDING BIOEQUIVALENCE STUDY SUMMARY TABLES AND SAS TRANSPORT FORMATTED TABLES FOR DATASET SUBMISSION

IN VITRO BINDING BIOEQUIVALENCE STUDY SUMMARY TABLES AND SAS TRANSPORT FORMATTED TABLES FOR DATASET SUBMISSION IN VITRO BINDING BIOEQUIVALENCE STUDY SUMMARY TABLES AND SAS TRANSPORT FORMATTED TABLES FOR DATASET SUBMISSION I. For Calcium Acetate Drug Products Table I.1 Submission Summary * Drug Product Name Strength(s)

More information

Guideline on Process Validation

Guideline on Process Validation 1 2 3 4 29 March 2012 EMA/CHMP/CVMP/QWP/70278/2012-Rev1 Committee for Medicinal Products for Human Use (CHMP) Committee for Medicinal Products for Veterinary Use (CVMP) 5 6 Draft Draft Agreed by CHMP /

More information

Quality by Design Approaches to Analytical Methods -- FDA Perspective. Yubing Tang, Ph.D. FDA/CDER/ONDQA AAPS, Washington DC October 25, 2011

Quality by Design Approaches to Analytical Methods -- FDA Perspective. Yubing Tang, Ph.D. FDA/CDER/ONDQA AAPS, Washington DC October 25, 2011 Quality by Design Approaches to Analytical Methods -- FDA Perspective Yubing Tang, Ph.D. FDA/CDER/ONDQA AAPS, Washington DC October 25, 2011 1 Outline What is Quality by Design (QbD) Role of Analytical

More information

GENERAL GUIDANCE FOR INSPECTORS ON HOLD-TIME STUDIES

GENERAL GUIDANCE FOR INSPECTORS ON HOLD-TIME STUDIES February 2013 RESTRICTED GENERAL GUIDANCE FOR INSPECTORS ON HOLD-TIME STUDIES DRAFT FOR COMMENT Should you have any comments on the attached text, please send these to Dr Sabine Kopp, Manager, Medicines

More information

11.I In-process control Authors: Dr. Christian Gausepohl / Paolomi Mukherji / Update 07

11.I In-process control Authors: Dr. Christian Gausepohl / Paolomi Mukherji / Update 07 In-process control In-process control Authors: Dr. Christian Gausepohl / Paolomi Mukherji / Update 07 Here you will find answers to the following questions: What are the in-process control tasks? Where

More information

Workshop A Design Space (DS)

Workshop A Design Space (DS) Implementation of ICH Q8, Q9, Q10 Workshop A Design Space (DS) International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Disclaimer The information

More information

Performance Evaluation of Actimask 92S Ibuprofen: A Novel Taste-Masked Ibuprofen for Use in Orally-Dispersible Dosage Forms

Performance Evaluation of Actimask 92S Ibuprofen: A Novel Taste-Masked Ibuprofen for Use in Orally-Dispersible Dosage Forms Performance Evaluation of Actimask 92S Ibuprofen: A Novel Taste-Masked Ibuprofen for Use in Orally-Dispersible Dosage Forms Author: Brian D. Wilson Background Recently, orally-dispersible dosage forms,

More information

PHARMACEUTICAL DEVELOPMENT

PHARMACEUTICAL DEVELOPMENT INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE PHARMACEUTICAL DEVELOPMENT Q8(R2) Current Step

More information

Multivariate Tools for Modern Pharmaceutical Control FDA Perspective

Multivariate Tools for Modern Pharmaceutical Control FDA Perspective Multivariate Tools for Modern Pharmaceutical Control FDA Perspective IFPAC Annual Meeting 22 January 2013 Christine M. V. Moore, Ph.D. Acting Director ONDQA/CDER/FDA Outline Introduction to Multivariate

More information

Implementing New USP Chapters for Analytical Method Validation

Implementing New USP Chapters for Analytical Method Validation Implementing New USP Chapters for Analytical Method Validation March 2010 Ludwig Huber Fax.: +49 7243 602 501 E-mail: Ludwig_Huber@labcompliance.com Today s Agenda Handling Method Changes vs. Adjustments

More information

Directly compressed mini-tablets coated in a solid-wall pan for sustained drug release

Directly compressed mini-tablets coated in a solid-wall pan for sustained drug release Directly compressed mini-tablets coated in a solid-wall pan for sustained drug release March 2012 N. Passerini, B. Albertini, L.Rodriguez Department of Pharmaceutical Sciences, University of Bologna C.

More information

PRODUCT DEVELOPMENT GUIDE

PRODUCT DEVELOPMENT GUIDE PRODUCT DEVELOPMENT GUIDE PRE-FORMULATION - TABLETS Introduction Guidelines for the development of a ANDA product for the US market, Note: some tests or procedures may be unnecessary. The order of performing

More information

2.3 QUALITY OVERALL SUMMARY Sakura Tablet

2.3 QUALITY OVERALL SUMMARY Sakura Tablet English Mock QOS P2_Final_June08 MODULE 2: COMMON TECHNICAL DOCUMENT SUMMARIES Generic name: Amokinol 2.3 QUALITY OVERALL SUMMARY Sakura Tablet 1 English Mock QOS P2 Final TABLE OF CONTENTS Page Table

More information

Pharmaceutical Quality Systems: US Perspective

Pharmaceutical Quality Systems: US Perspective Pharmaceutical Quality Systems: US Perspective Rick Friedman Associate Director, Office of Manufacturing and Product Quality Center for Drug Evaluation and Research Topics Background: The ICH Q10 Pharmaceutical

More information

Process Systems Engineering in Pharmaceutical Development & Manufacture

Process Systems Engineering in Pharmaceutical Development & Manufacture Process Systems Engineering in Pharmaceutical Development & Manufacture G.V. Rex Reklaitis School of Chemical Engineering Purdue University In Sympathy with Tom Edgar s 65 th Birthday NSF ERC FOR STRUCTURED

More information

Calibration & Preventative Maintenance. Sally Wolfgang Manager, Quality Operations Merck & Co., Inc.

Calibration & Preventative Maintenance. Sally Wolfgang Manager, Quality Operations Merck & Co., Inc. Calibration & Preventative Maintenance Sally Wolfgang Manager, Quality Operations Merck & Co., Inc. Calibration: A comparison of two instruments or measuring devices one of which is a standard of known

More information

Vinod et al., ARPB, 2013; Vol 3 (II) ISSN 2250-0774

Vinod et al., ARPB, 2013; Vol 3 (II) ISSN 2250-0774 Vinod et al., ARPB, 2013; Vol 3 (II) ISSN 2250- (RESEARC ARTICLE) QUALIFICATION OF EQUIPMENT: SAIZONER MIXER GRANULATOR, COMPRESSION MACINE AND COATING PAN * J. Vinod and A. Chenthilnathan Department of

More information

Q8(R2): Pharmaceutical Development

Q8(R2): Pharmaceutical Development ICH-GCG ASEAN Q8(R2): Pharmaceutical Development Jean-Louis ROBERT, Ph.D. National Health Laboratory, Luxembourg Chair-person ICH IWG Q8, Q9, Q10 Kuala Lumpur, 26-28 July 2010 International Conference

More information

Validation and Calibration. Definitions and Terminology

Validation and Calibration. Definitions and Terminology Validation and Calibration Definitions and Terminology ACCEPTANCE CRITERIA: The specifications and acceptance/rejection criteria, such as acceptable quality level and unacceptable quality level, with an

More information

Making Improvement Work in Pharmaceutical Manufacturing Some Case Studies. Ronald D. Snee

Making Improvement Work in Pharmaceutical Manufacturing Some Case Studies. Ronald D. Snee Making Improvement Work in Pharmaceutical Manufacturing Some Case Studies Ronald D. Snee ISPE Midwest Extended Education and Vendor Day Overland Park, KS 2 May 2007 King of Prussia PA New York NY Washington

More information

STARCH 1500. Application Data

STARCH 1500. Application Data STARCH 1500 Application Data Partially Pregelatinized Maize Starch Starch 1500, Partially Pregelatinized Maize Starch, Used as a Binder Disintegrant in High Shear Wet Granulation Comparison to Povidone

More information

A Preliminary Proposal for a Pharmaceutical Engineering Graduate Program

A Preliminary Proposal for a Pharmaceutical Engineering Graduate Program A Preliminary Proposal for a Pharmaceutical Engineering Graduate Program Planning Committee: Prabir Basu Steve Byrn Ken Morris Rex Reklaitis Paul Sojka Venkat Venkatasubramanian Carl Wassgren National

More information

Control Strategy Case Studies

Control Strategy Case Studies Control Strategy Case Studies Vance Novack, GSK Workshop on Implementation of ICH Q8/Q9/Q10 and Other Quality Guidelines Beijing, China, Dec 2008 Control Strategy Case Studies The information and knowledge

More information

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Review Article

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Review Article INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Review Article INDUSTRIAL PROCESS VALIDATION OF TABLET DOSAGE FORM: AN OVERVIEW Gupta Surbhi 1 *, Saini Seema 1, Singh Gurpreet

More information

ICH guideline Q8, Q9 and Q10 - questions and answers volume 4

ICH guideline Q8, Q9 and Q10 - questions and answers volume 4 December 2010 EMA/CHMP/ICH/265145/ Committee for medicinal products for human use (CHMP) ICH guideline Q8, Q9 and Q10 - questions and answers volume 4 Step 5 Transmission to CHMP for information December

More information

QbD Considerations for Analytical Methods - FDA Perspective

QbD Considerations for Analytical Methods - FDA Perspective QbD Considerations for Analytical Methods - FDA Perspective IFPAC Annual Meeting Baltimore, January 25, 2013 Sharmista Chatterjee, Ph.D. CMC Lead for QbD ONDQA/CDER/FDA Outline Role of analytics in drug

More information

International Research Journal of Pharmaceutical and Applied Sciences Available online at www.irjpas.com. Int. Res J Pharm. App Sci.

International Research Journal of Pharmaceutical and Applied Sciences Available online at www.irjpas.com. Int. Res J Pharm. App Sci. International Research Journal of Pharmaceutical and Applied Sciences Available online at www.irjpas.com Int. Res J Pharm. App Sci., 2012; 2(4):1-16 Research Article Process Validation of Benazepril HCl

More information

Methods for the preparation of the test sample from the laboratory sample (Part 1 Material & Methods) Work Package 6 Task 6.4

Methods for the preparation of the test sample from the laboratory sample (Part 1 Material & Methods) Work Package 6 Task 6.4 Methods for the preparation of the test sample from the laboratory sample (Part 1 Material & Methods) Work Package 6 Task 6.4 Validation of prcen/ts 15413 (WI 343027) Paolo de Zorzi APAT - Italian Environmental

More information

The importance of normalisation when comparing tablet properties

The importance of normalisation when comparing tablet properties The importance of normalisation when comparing tablet properties Tablet quality definition The properties of a tablet, both during manufacturing and in vivo, are determined by the properties of the materials

More information

Continuous Granulation and Drying

Continuous Granulation and Drying Continuous Granulation and Drying Collette TM Technologies GEA Pharma Systems GEA Pharma Systems supplies advanced technologies for the processing of Active Pharmaceutical Ingredients (API) for the production

More information

Quality by Design for ANDAs: An Example for Modified Release Dosage Forms

Quality by Design for ANDAs: An Example for Modified Release Dosage Forms Quality by Design for ANDAs: An Example for Modified Release Dosage Forms Introduction to the Example This is an example pharmaceutical development report illustrating how ANDA applicants can move toward

More information

PROCESS VALIDATION OF TABLETS: AN OVERVIEW

PROCESS VALIDATION OF TABLETS: AN OVERVIEW PROCESS VALIDATION OF TABLETS: AN OVERVIEW Vikas Verma 1*, Ujjwal Nautiyal 1, M. Senthil Kumar 1, Chandra Kant 1 1 Department of Pharmacy, Himachal institute of Pharmacy, Paonta Sahib, (H.P), India. ABSTRACT

More information

Process Validation of Solid Oral Dosage Forms, Part I General Principles

Process Validation of Solid Oral Dosage Forms, Part I General Principles Process Validation of Solid Oral Dosage Forms, Part I General Principles İKEV Meeting June 1, 2001 Scott Bozzone, Ph.D. Quality Operations Cork, Ireland European Commission: European definition 1991 -

More information

B i o s o l u t i o n s

B i o s o l u t i o n s B i o s o l u t i o n s Implementation of pharmatracker TM : A case study Prepared by Ocimum Biosolutions Ocimumbio Solutions August 2006 All rights reserved. 2 B i o s o l u t i o n s an ISO 9001:2000

More information

UTS Extended with visioNIR by Kraemer & Ischi Tablet testing equipment for checking Hardness, Diameter, Thickness, Weight and active pharmaceutical ingredient (API)

UTS Extended with visioNIR by Kraemer & Ischi
Tablet testing equipment for checking Hardness, Diameter, Thickness, Weight and active pharmaceutical ingredient (API) Testing T Systems for In-Process Control By Kraemer & Ischi STANDARD DEVICE UTS EXTENDEDD Automatic testing system with VisioNIR MEASURED PARAMETERS WEIGHT Nowadays, batches easily reach sizes of > 1,000,000

More information

Evaluating Current Practices in Shelf Life Estimation

Evaluating Current Practices in Shelf Life Estimation Definition of Evaluating Current Practices in Estimation PQRI Stability Working Group Pat Forenzo Novartis James Schwenke Applied Research Consultants, LLC From ICH Q1E An appropriate approach to retest

More information

Advancements in continuous tablet coating Jim Marjeram O Hara Technologies

Advancements in continuous tablet coating Jim Marjeram O Hara Technologies Advancements in continuous tablet coating Jim Marjeram O Hara Technologies 16 October 2008 0 Agenda Background on tablet coating Motivation for continuous processing Current continuous coating capability

More information

Content Uniformity (CU) testing for the 21 st Century: CDER Perspective

Content Uniformity (CU) testing for the 21 st Century: CDER Perspective Content Uniformity (CU) testing for the 21 st Century: CDER Perspective Richard (Rik) Lostritto, Ph.D. Acting Deputy Office Director for Science and Policy and Biopharmaceutics Lead Office of New Drug

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Q8, Q9, and Q10 Questions and Answers(R4) U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics

More information

Innovative vs Traditional

Innovative vs Traditional And in the red corner, introducing the challenger NASDAQ April 4 2011 243.47 $ 1.38 $ 0.58 % 0.07 $ 0.02 $ 39.4 % Technology DVD Digital Streamline Instant Play Internet Access Unlimited Selection No Late

More information

XL 200. Pharmaceutical Rotary Press. For Mid-Range Production

XL 200. Pharmaceutical Rotary Press. For Mid-Range Production XL 200 Pharmaceutical Rotary Press For Mid-Range Production Innovations Made in Berlin Since 1919 Focus Drives Perfection Specialization is the key. Since 1919, KORSCH has focused on its core competency

More information

Operating Principle of the Sample Positioning Flaps

Operating Principle of the Sample Positioning Flaps Test WEIGHT, THICKNESS, DIAMETER (or LENGTH), and HARDNESS of regular tablets, odd shaped tablets (caplets, oblongs etc.) and other solid samples fully automatically. Use the WHT 3ME for the fully automated

More information

Step-by-Step Analytical Methods Validation and Protocol in the Quality System Compliance Industry

Step-by-Step Analytical Methods Validation and Protocol in the Quality System Compliance Industry Step-by-Step Analytical Methods Validation and Protocol in the Quality System Compliance Industry BY GHULAM A. SHABIR Introduction Methods Validation: Establishing documented evidence that provides a high

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Tablet Scoring: Nomenclature, Labeling, and Data for Evaluation U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER)

More information

QUALITY BY DESIGN (QBD) : A COMPLETE REVIEW

QUALITY BY DESIGN (QBD) : A COMPLETE REVIEW Review Article QUALITY BY DESIGN (QBD) : A COMPLETE REVIEW Nishendu P. Nadpara*, Rakshit V. Thumar, Vidhi N. Kalola, Parula B. Patel Department of Quality Assurance, S. J. Thakkar Pharmacy College, Opp.

More information

ANDA CHECKLIST FOR CTD or ectd FORMAT FOR COMPLETENESS and ACCEPTABILITY of an APPLICATION FOR FILING

ANDA CHECKLIST FOR CTD or ectd FORMAT FOR COMPLETENESS and ACCEPTABILITY of an APPLICATION FOR FILING ANDA CHECKLIST FOR CTD or ectd FORMAT FOR COMPLETENESS and ACCEPTABILITY of an APPLICATION FOR FILING For More Information on Submission of an ANDA in Electronic Common Technical Document (ectd) Format

More information

Solid dosage forms testing: Disintegration test and tablet friability and hardness

Solid dosage forms testing: Disintegration test and tablet friability and hardness Specialized Laboratory for Drug production (N111049) Instructions Solid dosage forms testing: Disintegration test and tablet friability and hardness Tutor: Ing. Jiří Petrů Study program: Drug synthesis

More information

TESTIMONIAL: Congratulations! Our company s EID Incoming Inspection of AMRESCO-provided products

TESTIMONIAL: Congratulations! Our company s EID Incoming Inspection of AMRESCO-provided products custom solutions With markets changing so rapidly, AMRESCO is on the front line bringing new technologies and processes so we can deliver solutions that solve our customers problems. TESTIMONIAL: Congratulations!

More information

Generic drugs are copies of innovator drug products

Generic drugs are copies of innovator drug products dx.doi.org/10.14227/dt190412p51 In Vitro Equivalence Studies of Generic Metformin Hydrochloride Tablets and Propranolol Hydrochloride Tablets Under Biowaiver Conditions in Lagos State, Nigeria e-mail:

More information

Post-Approval Change Management: Challenges and Opportunities An FDA Perspective

Post-Approval Change Management: Challenges and Opportunities An FDA Perspective CMC Workshop From Drug Development to Global Supply to Patients April 15-17, 2013, Washington, DC Post-Approval Change Management: Challenges and Opportunities An FDA Perspective Christine M. V. Moore,

More information

Preparing for the Pre-Approval Inspection What to do Before the FDA Arrives. Barry A. Friedman, Ph.D. Consultant

Preparing for the Pre-Approval Inspection What to do Before the FDA Arrives. Barry A. Friedman, Ph.D. Consultant Preparing for the Pre-Approval Inspection What to do Before the FDA Arrives Barry A. Friedman, Ph.D. Consultant FDA Overview FDA is a consumer protection agency within the Department of Health & Human

More information

Continuous manufacturing moving towards real-time release. Creating innovations for the pharmaceutical industry. siemens.

Continuous manufacturing moving towards real-time release. Creating innovations for the pharmaceutical industry. siemens. Continuous manufacturing moving towards real-time release Creating innovations for the pharmaceutical industry siemens.com/pharma Strategic partnership Creative ideas and industry expertise A move to continuous

More information

Chapter 11. MRP and JIT

Chapter 11. MRP and JIT Chapter 11 MRP and JIT (Material Resources Planning and Just In Time) 11.1. MRP Even if MRP can be applied among several production environments, it has been chosen here as a preferential tool for the

More information

AS9100 Quality Manual

AS9100 Quality Manual Origination Date: August 14, 2009 Document Identifier: Quality Manual Revision Date: 8/5/2015 Revision Level: Q AS 9100 UNCONTROLLED IF PRINTED Page 1 of 17 1 Scope Advanced Companies (Advanced) has established

More information

Process Analytical Technology (PAT) Capabilities and Implementations under QbD Principles QbD and PAT Department

Process Analytical Technology (PAT) Capabilities and Implementations under QbD Principles QbD and PAT Department Process Analytical Technology (PAT) Capabilities and Implementations under QbD Principles QbD and PAT Department K1 Competence Center Initiated by the Federal Ministry of Transport, Innovation & Technology

More information

Guide to Inspections of Tablet Manufacturing Facilities including Pre/Post Approval Issues as per USFDA

Guide to Inspections of Tablet Manufacturing Facilities including Pre/Post Approval Issues as per USFDA International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 0974-4304 Vol.4, No.1, pp 49-55, Jan-Mar 2012 Guide to Inspections of Tablet Manufacturing Facilities including Pre/Post Approval

More information

The Effect of Coating Process Conditions and Coating Formula Type on the Quantity and Location of Water in Film Coated Tablets

The Effect of Coating Process Conditions and Coating Formula Type on the Quantity and Location of Water in Film Coated Tablets OPADRY II Application Data High Performance Film Coating System The Effect of Coating Process Conditions and Coating Formula Type on the Quantity and Location of Water in Film Coated Tablets OBJECTIVES

More information

Multi- and Megavariate Data Analysis

Multi- and Megavariate Data Analysis Multi- and Megavariate Data Analysis Basic Principles and Applications Third revised edition L. Eriksson, T. Byrne, E. Johansson, J. Trygg and C. Vikström Chapter 18 Process Analytical Technology (PAT)

More information

How To Test For Contamination In Large Volume Water

How To Test For Contamination In Large Volume Water Automated Solid Phase Extraction (SPE) of EPA Method 1694 for Pharmaceuticals and Personal Care Products in Large Volume Water Samples Keywords Application Note ENV0212 This collaboration study was performed

More information

Pharmaceutical Rotary Presses. PharmaPress 800. High Speed Double Rotary Press

Pharmaceutical Rotary Presses. PharmaPress 800. High Speed Double Rotary Press Pharmaceutical Rotary Presses PharmaPress 800 High Speed Double Rotary Press Highest Output with... The KORSCH PharmaPress 800 is a high capacity, double sided tablet press for fully automated and unattended

More information

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS ANNEX 15 *

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS ANNEX 15 * PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PS/INF 11/2015 1 April 2015 GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS ANNEX 15 * * Entry into force:

More information

International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation

International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation Ludwig Huber, Ph.D. ludwig_huber@labcompliance.com Overview GMP requirements for Quality Control laboratories

More information

Table 1. Pure superdisintegrant tablet formulation. Material % w/w Weight (mg) Superdisintegrant 99 277.2 Stearic acid 1 2.

Table 1. Pure superdisintegrant tablet formulation. Material % w/w Weight (mg) Superdisintegrant 99 277.2 Stearic acid 1 2. PHARMACEUTICAL TECHNOLOGY REPORT Ashland Specialty Ingredients ashland.com PTR-95 Page 1 of 5 Utility of Polyplasdone as a Tablet Binder Quyen Schwing, Marvin Davis, Divya Tewari, Thomas Dürig Ashland

More information

Welcome Computer System Validation Training Delivered to FDA. ISPE Boston Area Chapter February 20, 2014

Welcome Computer System Validation Training Delivered to FDA. ISPE Boston Area Chapter February 20, 2014 Welcome Computer System Validation Training Delivered to FDA ISPE Boston Area Chapter February 20, 2014 1 Background Training Conducted on April 24, 2012 Food & Drug Administration Division of Manufacturing

More information

Method Development and Validation for Particle Size and Shape Measurements

Method Development and Validation for Particle Size and Shape Measurements Method Development and Validation for Particle Size and Shape Measurements Ulf Willén Divisional Product Manager Analytical Imaging Systems Malvern Instruments Ltd, Malvern, UK. FDA guidance: when should

More information

QbD Understanding How Excipient Properties Influence Solid Oral Dosage Form Performance

QbD Understanding How Excipient Properties Influence Solid Oral Dosage Form Performance QbD Understanding How Excipient Properties Influence Solid Oral Dosage Form Performance Dr Amina Faham (Dow), Dr Liz Meehan (AstraZeneca) ExcipientFest, Amsterdam NL June 24, 2014 What do you understand

More information

What is Process Validation?

What is Process Validation? What is Process Validation? Process Validation is defined as the collection and evaluation of data, from the process design stage throughout production, which establishes scientific evidence that a process

More information

Quality by Design Application and Perspectives for biologicals. K. Ho, CHMP Biologics Working Party

Quality by Design Application and Perspectives for biologicals. K. Ho, CHMP Biologics Working Party Quality by Design Application and Perspectives for biologicals K. Ho, CHMP Biologics Working Party Pharmaceutical development (Q8) Aim: To design a quality product and a manufacturing process to consistently

More information

Design of Experiments for Analytical Method Development and Validation

Design of Experiments for Analytical Method Development and Validation Design of Experiments for Analytical Method Development and Validation Thomas A. Little Ph.D. 2/12/2014 President Thomas A. Little Consulting 12401 N Wildflower Lane Highland, UT 84003 1-925-285-1847 drlittle@dr-tom.com

More information

Process analytical technology PAT for the life sciences industry

Process analytical technology PAT for the life sciences industry analytical technology PAT for the life sciences industry PAT for life sciences A quality by design (QbD) approach using process analytical technology (PAT) requires more than a collection of analyzers

More information

ANALYTICAL METHODS INTERNATIONAL QUALITY SYSTEMS

ANALYTICAL METHODS INTERNATIONAL QUALITY SYSTEMS VALIDATION OF ANALYTICAL METHODS 1 GERT BEUVING INTERNATIONAL PHARMACEUTICAL OPERATIONS TASKS: - Internal auditing - Auditing of suppliers and contract manufacturers - Preparing for and guiding of external

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Immediate Release Solid Oral Dosage Forms Scale-Up and Postapproval Changes: Chemistry, Manufacturing, and Controls, In Vitro Dissolution Testing, and In Vivo Bioequivalence Documentation

More information

Business Process Improvement in Life Sciences Manufacturing through the Integration of Information and Production Management Systems and Automation

Business Process Improvement in Life Sciences Manufacturing through the Integration of Information and Production Management Systems and Automation Business Process Improvement in Life Sciences Manufacturing through the Integration of Information and Production Management Systems and Automation ANTHONY V SOLLAZO Life Sciences Industry Solutions Manager

More information

Session 6: WHO Prequalification Programme. Key Process Steps WHO: Medicines UNFPA: Condoms and IUDs

Session 6: WHO Prequalification Programme. Key Process Steps WHO: Medicines UNFPA: Condoms and IUDs Session 6: WHO Prequalification Programme Key Process Steps WHO: Medicines UNFPA: Condoms and IUDs Session adapted from the WHO training workshop on prequalification and the WHO technical briefing seminar

More information

CypExpress 3A4 Catalyzed Conversion of Testosterone (TE) to 6β- Hydroxytestosterone (HT)

CypExpress 3A4 Catalyzed Conversion of Testosterone (TE) to 6β- Hydroxytestosterone (HT) TM CASE STUDY CypExpress 3A4 Catalyzed Conversion of to Shuvendu Das, 1 Enrique Martez, 2 and Mani Subramanian 1 1 Center for Biocatalysis and Bioprocessg, University of Iowa 2 Oxford Biomedical Research,

More information

EXTRUDER FEEDING SYSTEMS

EXTRUDER FEEDING SYSTEMS EXTRUDER FEEDING SYSTEMS www.kreyenborg-pt.com www.kreyenborg-group.com KREYENBORG GROUP BEST TECHNOLOGY INSIDE! The KREYENBORG GROUP is comprised of the following companies: KREYENBORG GmbH, BKG Bruckmann

More information

Guidance for Industry Tablet Scoring: Nomenclature, Labeling, and Data for Evaluation

Guidance for Industry Tablet Scoring: Nomenclature, Labeling, and Data for Evaluation Guidance for Industry Tablet Scoring: Nomenclature, Labeling, and Data for Evaluation DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding

More information

Process Validation: Practical Aspects of the New FDA Guidance

Process Validation: Practical Aspects of the New FDA Guidance Process Validation: Practical Aspects of the New FDA Guidance ISPE Boston Chapter Meeting April 18, 2013 Rusty Morrison Commissioning Agents, Inc. Objectives / Summary What is Process Validation? Regulatory

More information

Review Article Available online at www.jgtps.com

Review Article Available online at www.jgtps.com Review Article Available online at www.jgtps.com A REVIEW ON QUALIFICATION OF AUTOCLAVE, RMG, FBD, CONE BLENDER, TABLET COMPRESSION MACHINE B.Venkateswara Reddy* 1, B.Rasmitha Reddy 1, K.Navaneetha 1,

More information

Case Study Development Assessment Implementation Inspection

Case Study Development Assessment Implementation Inspection Implementation of ICH Q8, Q9, Q10 Development Assessment Implementation Inspection International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use

More information

IN-LINE PARTICLE SIZE MEASUREMENTS FOR CEMENT AND OTHER ABRASIVE PROCESS ENVIRONMENTS

IN-LINE PARTICLE SIZE MEASUREMENTS FOR CEMENT AND OTHER ABRASIVE PROCESS ENVIRONMENTS IN-LINE PARTICLE SIZE MEASUREMENTS FOR CEMENT AND OTHER ABRASIVE PROCESS ENVIRONMENTS 1998 A.P. Malcolmson Malvern, Inc. 10 Southville Road Southborough, MA D. J. Holve Malvern/Insitec, Inc. 2110 Omega

More information

Uniformity of Dosage Units (BP 2011 & USP 34) Ms. Witinee Kongsuk Bureau of Drug and Narcotic Department of Medical Sciences June 14, 2011

Uniformity of Dosage Units (BP 2011 & USP 34) Ms. Witinee Kongsuk Bureau of Drug and Narcotic Department of Medical Sciences June 14, 2011 Uniformity of Dosage Units (BP 2011 & USP 34) Ms. Witinee Kongsuk Bureau of Drug and Narcotic Department of Medical Sciences June 14, 2011 1 Outline : Definition Harmonized general chapter USP 34

More information

Revision of The Dissolution Procedure: Development and Validation 1092

Revision of The Dissolution Procedure: Development and Validation 1092 Page 1 of 5 STIMULI TO THE REVISION PROCESS Stimuli articles do not necessarily reflect the policies of the USPC or the USP Council of Experts Revision of The Dissolution Procedure: Development and Validation

More information

Tableting Punch Performance Can Be Improved With Precision Coatings

Tableting Punch Performance Can Be Improved With Precision Coatings Tableting Punch Performance Can Be Improved With Precision Coatings by Arnold H. Deutchman, Ph. D. Director of Research and Development (614) 873-4529 X 114 adeutchman@beamalloy.net Mr. Dale C. Natoli

More information

Prescription drug products stability and expiration dates*

Prescription drug products stability and expiration dates* Prescription drug products stability and expiration dates* UTMB/NASA-JSC Aerospace Medicine Grand Rounds Houston, TX October 27, 2009 Mansoor A. Khan, R.Ph., Ph.D. Director, FDA/CDER/Division of Product

More information

Introducing the Improved MAS DRD "Waterless" Cleaning System for Plastic Film, Flakes and Fibers

Introducing the Improved MAS DRD Waterless Cleaning System for Plastic Film, Flakes and Fibers PRESS RELEASE - For Immediate Distribution Introducing the Improved MAS DRD "Waterless" Cleaning System for Plastic Film, Flakes and Fibers September 28, 2015 - The Upper Austrian plastics machinery manufacturer

More information

Research needs in pharmaceutical excipients: implications of a global supply chain

Research needs in pharmaceutical excipients: implications of a global supply chain Research needs in pharmaceutical excipients: implications of a global supply chain FY 2015 GDUFA Regulatory Science Initiatives Part 15 Public Meeting June 5, 2015 Silver Spring, MD Stephen W. Hoag, Ph.D.

More information

whitepaper Impact of Formula- on Pharmaceutical Manufacturers www.aptean.com

whitepaper Impact of Formula- on Pharmaceutical Manufacturers www.aptean.com whitepaper Impact of Formula- Based ERP Applications on Pharmaceutical Manufacturers WHITEPAPER Essentials for pharmaceutical manufacturers 2 about Whether you re in the process of re-evaluating your existing

More information

White paper: FDA Guidance for Industry Update Process Validation

White paper: FDA Guidance for Industry Update Process Validation White paper: FDA Guidance for Industry Update Process Validation In January 2011, the FDA released the final version of its long-awaited update to its Process Validation Guidance for Industry. Since then,

More information

Fundamentals of Tablet Compression

Fundamentals of Tablet Compression PHARMACEUTICAL PROCESSES Fundamentals of Tablet Compression Armin H. Gerhardt GLOWIMAGES/GETTY IMAGES Pharmaceutical Processes discusses scientific and technical principles associated with pharmaceutical

More information

DVD-R/CD-R 3503 DVD-R/CD-R 3503. your gateway to the future

DVD-R/CD-R 3503 DVD-R/CD-R 3503. your gateway to the future DVD-R/CD-R DVD-R/CD-R your gateway to the future 2 DVD-R/CD-R HIGHLIGHTS Highlights DVD-R Very compact high performance production tool for DVD-R and CD-R production Small footprint of only 25 m 2 Low

More information

Flour Milling Process Analysis Get more out of your production with High Resolution in-line analysis. ProFoss. Dedicated Analytical Solutions

Flour Milling Process Analysis Get more out of your production with High Resolution in-line analysis. ProFoss. Dedicated Analytical Solutions Flour Milling Process Analysis Get more out of your production with High Resolution in-line analysis ProFoss Dedicated Analytical Solutions Get a clearer picture of your flour milling production with High

More information

The ability of a manufacturing process to

The ability of a manufacturing process to Exclusive On-Line Article PHARMACEUTICAL ENGINEERING The Official Magazine of ISPE November/December 2006, Vol. 26 No. 6 The Product Quality Research Institute (PQRI) is collaborative effort between the

More information

Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations

Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations Kevin O Donnell PhD Market Compliance Manager, IMB PDA / FDA Conference Pharmaceutical

More information